- Home
- ASRT vs ZYXI Comparison
ASRT vs ZYXI Comparison
Compare ASRT & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRT
- ZYXI
- Stock Information
- Founded
- ASRT 1995
- ZYXI 1996
- Country
- ASRT United States
- ZYXI United States
- Employees
- ASRT N/A
- ZYXI N/A
- Industry
- ASRT Biotechnology: Pharmaceutical Preparations
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ASRT Health Care
- ZYXI Health Care
- Exchange
- ASRT Nasdaq
- ZYXI Nasdaq
- Market Cap
- ASRT 57.9M
- ZYXI 66.5M
- IPO Year
- ASRT 1997
- ZYXI N/A
- Fundamental
- Price
- ASRT $0.65
- ZYXI $2.49
- Analyst Decision
- ASRT Strong Buy
- ZYXI Buy
- Analyst Count
- ASRT 2
- ZYXI 3
- Target Price
- ASRT $3.25
- ZYXI $6.00
- AVG Volume (30 Days)
- ASRT 207.4K
- ZYXI 204.8K
- Earning Date
- ASRT 08-06-2025
- ZYXI 07-24-2025
- Dividend Yield
- ASRT N/A
- ZYXI N/A
- EPS Growth
- ASRT N/A
- ZYXI N/A
- EPS
- ASRT N/A
- ZYXI N/A
- Revenue
- ASRT $119,001,000.00
- ZYXI $172,401,000.00
- Revenue This Year
- ASRT N/A
- ZYXI N/A
- Revenue Next Year
- ASRT $11.91
- ZYXI $19.55
- P/E Ratio
- ASRT N/A
- ZYXI N/A
- Revenue Growth
- ASRT N/A
- ZYXI N/A
- 52 Week Low
- ASRT $0.51
- ZYXI $1.66
- 52 Week High
- ASRT $1.80
- ZYXI $10.62
- Technical
- Relative Strength Index (RSI)
- ASRT 49.30
- ZYXI 56.22
- Support Level
- ASRT $0.60
- ZYXI $1.99
- Resistance Level
- ASRT $0.68
- ZYXI $2.47
- Average True Range (ATR)
- ASRT 0.03
- ZYXI 0.15
- MACD
- ASRT -0.00
- ZYXI 0.04
- Stochastic Oscillator
- ASRT 67.00
- ZYXI 91.46
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.